360°CDMO and CRO solutions
Developing novel therapies and delivering them to patients is high-risk. Adding multiple vendors to the mix increases complexity and delays timelines. As the industry’s only fully integrated CDMO and CRO, we provide seamless support at every step.
From drug substance to drug product development to clinical trial research, manufacturing, supply optimization, and logistics through to commercialization, we are committed to supporting your aspiration to get treatments to patients faster.
We combine proven end-to-end capabilities and state-of-the-art technologies with a dedicated team of global subject matter experts to simplify and streamline your drug development journey, getting you to the clinic—and to market—quicker.
Our unique approach fosters collaboration and transparency across all phases, helping to drive speed, simplicity, and scalability.
Integrated timelines, joint project management, and streamlined information sharing
Personalized planning and transparency across supply chains
Global networks with regional expertise for scale-up across geographies
Introducing AcceleratorTM Drug Development, 360° CDMO and CRO solutions
How do customers benefit from AcceleratorTM Drug Development?
How does Thermo Fisher Scientific compare to other companies?
With flexible and fully integrated CDMO and CRO capabilities, Thermo Fisher Scientific offers a comprehensive suite of world-class services and solutions across the drug development spectrum—from scientific discovery and assessing safety, efficacy, and outcomes, to managing clinical trial logistics and final drug product manufacturing.
Our Quick to Care™ program is designed to streamline your drug substance and drug product development, demand planning, and clinical trial supply execution into a single, customized solution. We simplify your supply chain and accelerate drug development with a seamless, one-team approach. Unlike managing multiple vendors, this single-vendor solution offers advantages across the continuum, including:
Now more than ever, you’re asked to do more in less time. Our Quick to Clinic™ program is a speed-focused solution tailored for small and large molecule drug development, as well as viral vector services. Quick to Clinic™ is designed to accelerate early development while using a proven process platform, ensuring that critical details are never overlooked.
120+ biotech and pharma companies have partnered with Thermo Fisher Scientific across our CDMO and CRO services on 350+ protocols.
With our breadth of experience, scientific expertise, and globally integrated network, we offer customizable solutions to shorten your drug development timeline and accelerate your path to market. We apply a science-driven, risk-based approach at every stage of development, manufacturing, and research, leveraging our global footprint and specialized scientific and therapeutic expertise to ensure your discovery reaches the patients who need it most.
We have one shared commitment: To accelerate your time to market.